Research and Markets : GSK Lobbies the UK Government On Key Issues
Research and Markets (researchandmarkets. com/reports/c15046) has announced the addition of Corporate Focus Healthcare: GlaxoSmithKline Q4 2004 to their offering.
Dublin (PRWEB) April 6, 2005
Research and Markets (http://www. researchandmarkets. com/reports/c15046 (http://www. researchandmarkets. com/reports/c15046)) has announced the addition of Corporate Focus Healthcare: GlaxoSmithKline Q4 2004 to their offering.
GlaxoSmithKline has been lobbying the UK government on a number of fronts. This is looking to shift the governmentÂ’s stance in areas such as the sale of nicotine-replacement products. GlaxoSmithKline argues, in this case, that sales of cigarettes are allowed where smoking cessation products cannot be sold and, therefore, smokers are not encouraged to buy them.
The GlaxoSmithKline newsletter covers the global consumer healthcare activities of GlaxoSmithKline during the final quarter of 2004.
Topics Include:
-The marketing environment.
-Nine-month sales fall.
-Acquisitions & Disposals.
-Executive changes.
-Communications & agency news.
-Smoking Cessation.
-Analgesics.
-Cough, Cold, Allergy.
-Dermatological.
-Gastro-intestinal.
-Oral Care.
-Nutritional Healthcare.
-DTC update.
For more information visit http://www. researchandmarkets. com/reports/c15046 (http://www. researchandmarkets. com/reports/c15046)
Laura Wood
Senior Manager
Research and Markets
Press@researchandmarkets. com
Fax: +353 1 4100 980
###
